Ignite Creation Date:
2024-05-06 @ 4:19 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04953819
Status:
UNKNOWN
Last Update Posted:
2021-07-08
First Post:
2021-06-16
Brief Title:
Coronary Revascularization in Patients With Dialysis in China
Sponsor:
China-Japan Friendship Hospital
Organization:
China-Japan Friendship Hospital
Study Overview
Official Title:
Coronary RevascUlarization in Patients With End-stage Renal dIsease on dialysiS in China a Nationwide and multicEnter Cohort Study
Status:
UNKNOWN
Status Verified Date:
2021-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CRUISE
Brief Summary:
China patients in end stage renal disease receiving maintenance dialysis have a high risk of cardiovascular disease CVD with a prevalence of 455 approximately and coronary artery disease CAD has been identified as the most common one It remains unclear that what their treatment status is and whether this group of patients can benefit from revascularization in China The investigators plan to recruit around 30 hospitals from 7 regions as study centers which represent different levels of economic development in Mainland China The detailed information includes demographics medical history coronary angiogram in-hospital treatment and procedures short-term and long-term outcomes The aim of the study is to provide the real world knowledge about current status of coronary revascularization and prognosis in patients with CAD and dialysis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None